Skip to Content

Mayo Clinic to lead national program on COVID-19 therapy

ROCHESTER, Minn. (KTTC) -- According to a news release Friday afternoon, Mayo Clinic has been named the lead institution by the Food and Drug Administration in a program that uses convalescent plasma as a way to treat COVID-19 patients.

According to the release, convalescent plasma refers to blood plasma collected from people who have recovered from COVID-19. That plasma is then used to treat others with advanced illness.

Mayo says the plasma donor must have recovered from, and tested negative for, COVID-19 and be otherwise healthy. The patient is transfused with the donor's plasma, which contains antibodies that can attack the virus and may help patients recover more rapidly.

Author Profile Photo

Kevin Millard

Kevin Millard-Social Media Digital Content Manager for WXOW.

Skip to content